New York 2025-2026 Regular Session

New York Assembly Bill A07409

Introduced

3/25/25

Refer

3/25/25

Refer

1/7/26

Caption

Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists; requires the department of health to approve all forms and doses of Naloxone approved by the FDA as opioid antagonists.

Latest NY A07409 Activity

View All Events: NY 2025-2026 Regular Session A07409

Companion Bills

No companion bills found.

Previously Filed As

NY LB5

Provide immunity for administration of naloxone or other federally approved opioid antagonists

NY SB503

Allow use of expired opioid antagonists

NY HB1767

Relating To Opioid Antagonists.

NY SB2855

Relating To Opioid Antagonists.

NY HB2697

expired opioid antagonists; use

NY HB907

Provides civil and criminal immunity for the distribution or use of Naloxone and other opioid antagonists beyond their shelf-life end date

NY HB1910

LIBRARIES-OPIOID ANTAGONISTS

NY HB310

Relating To Opioid Antagonists.

NY HB310

Relating To Opioid Antagonists.

NY HB431

AN ACT relating to opioid antagonists.

Similar Bills

KY HB6

AN ACT relating to administrative regulations and declaring an emergency.

KY HB422

AN ACT relating to administrative regulations.

KY SB23

AN ACT relating to administrative regulations and declaring an emergency.

KY SB20

AN ACT relating to administrative regulations and declaring an emergency.

KY HB494

AN ACT relating to administrative regulations.

HI SB3182

Relating To Administrative License Revocation.

KY HB81

AN ACT relating to governmental accountability and declaring an emergency.

HI HB2417

Relating To Administrative License Revocation.